导管室设施可及性对院外心脏骤停合并急性心肌梗死患者管理与结局的影响
该研究基于2010至2017年心肌缺血国家审计项目(MINAP)数据,纳入12,303例院外心脏骤停合并急性心肌梗死患者,按首诊医院导管室状态分为无导管室医院、诊断性导管室医院和PCI医院三组。PCI医院患者更常接受心脏科医生评估(96% vs 80% vs 74%,p<0.001)和冠状动脉造影(87% vs 31% vs 54%,p<0.001)及PCI(42% vs 17% vs 17%,p<0.001)。校正后,PCI医院与无导管室医院相比院内死亡率(OR 0.76,95%CI 0.55-1.06)和再梗死(OR 1.28,95%CI 0.72-2.26)无显著差异;诊断性导管室医院与无导管室医院相比亦无显著差异(死亡率OR 1.28,95%CI 0.72-2.26;再梗死OR 1.38,95%CI 0.68-2.82)。结论提示不同医院间冠状动脉造影使用存在差异,但未与更好的院内生存相关。
要点
- PCI医院患者心脏科医生评估率96%,高于无导管室医院80%和诊断性导管室医院74%(p<0.001)。
- PCI医院冠状动脉造影率87%,诊断性导管室医院31%,无导管室医院54%(p<0.001)。
- PCI医院PCI率42%,诊断性导管室医院17%,无导管室医院17%(p<0.001)。
- 校正后PCI医院与无导管室医院相比,院内死亡率OR 0.76(95%CI 0.55-1.06),再梗死OR 1.28(95%CI 0.72-2.26),均无显著差异。
- 诊断性导管室医院与无导管室医院相比,院内死亡率OR 1.28(95%CI 0.72-2.26),再梗死OR 1.38(95%CI 0.68-2.82),均无显著差异。
适用人群与场景
- 2010至2017年MINAP数据库中诊断为急性心肌梗死并发生院外心脏骤停的入院患者。
研究设计与关键结果
- 研究类型为基于MINAP数据库的分析,纳入12,303例患者,其中9,798例入住PCI医院,1,595例入住无导管室医院,910例入住诊断性导管室医院。
- PCI医院患者心脏科医生评估率96%,无导管室医院80%,诊断性导管室医院74%(p<0.001)。
- 冠状动脉造影率:PCI医院87%,诊断性导管室医院31%,无导管室医院54%(p<0.001)。
- PCI率:PCI医院42%,诊断性导管室医院17%,无导管室医院17%(p<0.001)。
- 校正后PCI医院与无导管室医院相比,院内死亡率OR 0.76(95%CI 0.55-1.06),再梗死OR 1.28(95%CI 0.72-2.26)。
- 校正后诊断性导管室医院与无导管室医院相比,院内死亡率OR 1.28(95%CI 0.72-2.26),再梗死OR 1.38(95%CI 0.68-2.82)。
证据类型、等级与局限
- 证据类型:基于MINAP数据库的观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论指出,无导管室医院与PCI中心之间冠状动脉造影使用存在差异,但该差异未与更好的院内生存相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We aimed to identify whether the availability of catheter laboratory affects clinical outcomes of out-of-hospital cardiac arrest (OHCA) complicating myocardial infarction (AMI).
METHODS: Patients admitted with a diagnosis of AMI and OHCA from the Myocardial Ischaemia National Audit Project (MINAP) between 2010 to 2017 were stratified into three groups based on initial hospital's catheter laboratory status: hospitals without a catheter laboratory (No-catheter lab hospitals), hospitals with diagnostic catheter laboratory (Diagnostic hospitals), and hospitals with PCI facilities (PCI hospitals). We used multivariable logistic regression to evaluate factors associated with clinical outcomes.
RESULTS: We included 12,303 patients of which 9,798 were admitted to PCI hospitals, 1,595 to no-catheter lab hospitals, and 910 to diagnostic hospitals. Patients admitted to PCI hospitals were more frequently reviewed by a cardiologist (96%, p < 0.001) than no-catheter lab hospitals (80%) and diagnostic hospitals (74%), and more likely to receive coronary angiography (PCI hospitals (87%), diagnostic hospitals (31%), no-catheter lab hospitals (54%), p < 0.001). They also were more likely to undergo PCI (PCI hospitals (42%), diagnostic hospitals (17%), no-catheter lab hospitals (17%), p < 0.001). After adjustment, there was no significant difference in the in-hospital mortality (OR 0.76, 95% CI 0.55-1.06) or re-infarction (OR 1.28, 95% CI 0.72-2.26) in patients admitted to PCI hospitals nor in patients admitted to diagnostic hospitals (mortality (OR 1.28, 95% CI 0.72-2.26), re-infarction (OR 1.38, 95% CI 0.68-2.82)).
CONCLUSION: There is variation in coronary angiography use between hospitals without a catheter laboratory and PCI centres, which was not associated with better in-hospital survival.
参考来源
- Dafaalla M, Rashid M, Sun L, et al. Impact of availability of catheter laboratory facilities on management and outcomes of acute myocardial infarction presenting with out of hospital cardiac arrest. Resuscitation. 2021. PMID: 34718080. doi:10.1016/j.resuscitation.2021.10.031
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。